Companies frequently encounter challenges in the manufacture and supply of their innovative products, in particular with respect to process development and production capacity.
In our latest webinar, we review how key issues are addressed in manufacture and supply agreements, both from the perspective of drug developers and manufacturers.
Our discussion points will include:
- Obligation to Supply in Development and Commercial Phases
- Managing Capacity Limitations
- Intellectual Property
- Regulatory Compliance
We are delighted to welcome Pierre-Louis Mikus, Chief Legal Officer of Novasep as our guest speaker.
Pierre-Louis Mikus is a member of the Quebec Bar and holds degrees, in law from the University of Montreal, and in management from ESCP Europe. Pierre-Louis joined Novasep in May 2015 as Chief Legal Officer.
He previously held top positions in the pharmaceutical industry, in particular as Vice President Legal – R&D and Technical Operations for a leading French biopharmaceutical group and, most recently, at a corporate law firm focusing on the life sciences sector.
Novasep is a global provider of cost effective and sustainable manufacturing solutions for life sciences molecules. Novasep’s offering includes process development services, purification equipment and turnkey processes, contract manufacturing and complex active molecule services for pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries.